Test Price
2,800 AEDโ Home Collection Available
CDC73 Gene Familial Parathyroid Adenoma with Cystic Changes Genetic Test in UAE
Executive Summary & Core Metrics
This next-generation sequencing test analyzes the entire coding region of the CDC73 gene to detect germline mutations linked to familial parathyroid adenoma with cystic changes, hyperparathyroidism-jaw tumor syndrome, and parathyroid carcinoma. Our test offers 99.9% diagnostic sensitivity through ISO 9001:2015 accredited NGS processing. We provide VIP mobile phlebotomy with temperature-controlled cold-chain home collection (daily 8 AMโ11 PM), telephonic post-test clinical guidance, and direct billing verification via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AMโ11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing (NGS) test analyzes the entire coding region of the CDC73 gene to detect germline mutations linked to familial parathyroid adenoma with cystic changes, hyperparathyroidism-jaw tumor syndrome, and parathyroid carcinoma. Early identification empowers risk-stratified surveillance, informed family planning, and preventive interventions under specialist guidance.
| Feature | Our Test (DNA Labs UAE) | Alternative Local Panels |
|---|---|---|
| Precision | 99.9% analytical sensitivity โ full gene sequencing with copy number variant detection | Limited to hotspot mutations; may miss large deletions |
| Method | NGS (Illumina platform) with orthogonal confirmation | Sanger sequencing or targeted genotyping |
| Turnaround | 3โ4 Weeks | 4โ8 Weeks |
| Home Collection | VIP cold-chain phlebotomy, 8 AMโ11 PM | Often unavailable or limited schedule |
Physician Insight & Safety Protocols
Advisory Notices
Do not discontinue any prescribed medication without consulting your doctor. Genetic test results should not be used as a sole basis for treatment changes.
Safety Exclusions & Emergency Red Flags
Exclusion Criteria: This test is not appropriate as a first-line evaluation for acute hypercalcemic crisis. Patients with concurrent severe uncontrolled hyperparathyroidism should receive urgent endocrinologic care before genetic sampling.
Seek Emergency Care if You Experience:
- Profound hypercalcemia (serum calcium >14 mg/dL) with confusion or coma
- Rapidly enlarging neck mass causing airway compression
- Severe nausea, vomiting, and cardiac arrhythmias
Patient FAQ & Clinical Guidance
1. What is the CDC73 gene test used for?
It detects inherited mutations in the CDC73 gene that cause familial parathyroid adenoma with cystic changes, hyperparathyroidism-jaw tumor syndrome, and parathyroid carcinoma. Early detection guides surveillance and surgical planning.
2. How is the sample collected and how long for results?
A simple blood draw or DNA from an FTA card is collected at home with cold-chain logistics, and results arrive in 3โ4 weeks. Our VIP phlebotomy service operates daily from 8 AM to 11 PM.
3. Is this test covered by UAE insurance?
Many UAE insurers cover genetic testing for inherited cancer syndromes when medically necessary; we offer direct billing verification via WhatsApp +971545488731. Coverage depends on policy terms and physician referral.
UAE Regulatory & Data Privacy Adherence
This test is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and stored locally in UAE servers. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory operations are ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CDC73 Gene Familial Parathyroid Adenoma with Cystic Changes Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood or FTA card (DNA) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (Illumina) with MLPA confirmation for copy number variants |
| ICD-10-CM Code | E21.0, D44.2, Z14.8 |
| LOINC Code | 21636-6 |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians